[Congestive heart failure].
D000086:Acetazolamide / Q000627:therapeutic use; D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000502:physiology; D001581:Benzothiadiazines; D002395:Catecholamines / Q000502:physiology; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds / Q000627:therapeutic use; D012083:Renin / Q000502:physiology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014667:Vasopressins / Q000502:physiology; D014882:Water-Electrolyte Balance
D001581:Benzothiadiazines; D002395:Catecholamines; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds; D049993:Sodium Chloride Symporter Inhibitors; D014667:Vasopressins; D000804:Angiotensin II; D000450:Aldosterone; D005665:Furosemide; D012083:Renin; D004976:Ethacrynic Acid; D000086:Acetazolamide